Alzheimers Disease Tips

December 24, 2006

Lithium-Like Drugs May Impair Neuronal Function

Filed under: Uncategorized — admin @ 12:08 am

Lithium-Like Drugs May Impair Neuronal Function
Forbes - THURSDAY, Dec. 21 (HealthDay News) — Too high a dose of lithium and other drugs that inhibit an enzyme called GSK-3 beta can impair, rather than improve, neurological function in patients with Alzheimer’s disease and should be used with caution, a

No snow job: Bring your boots to game
Denver Post - In lieu of flowers, the Bowlen family has asked that donations be made to AWARE, care of the Alzheimer’s Association of Colorado, 455 Sherman St., Suite 500, Denver, 80203. One game, one award for Steve Cargile. Having previously spent time on

‘We need more facilities as some families dump elderly parents’
Gulf News - Neuropsychiatric diseases associated with ageing, such as Alzheimer’s, are believed to be increasing as people live longer. Masoma Ahmad Abdullah, head of social services at the primary health care (PHC) level for the Department of Health and Medical

‘Humbled’ scientist is put on probation
Baltimore Sun - A leading government Alzheimer’s researcher told a federal judge in Baltimore yesterday that he had no good explanation for why he improperly accepted hundreds of thousands of dollars in undisclosed fees from a drug manufacturer while helping to

A Christmas lights story
SignOn San Diego - Her husband, James Sr., died of a heart attack in October 2004 at age 58. Then, her mother died earlier this year after a long struggle with Alzheimer’s disease. PEGGY PEATTIE / Union Tribune Jim Horton, with Candy the golden retriever, helped

Detecting Alzheimer’s earlier
WLS - This new technology scans the brain to find brain abnormalities which lead to Alzheimers, like plaque build-up and nerve tangles. Until now, the only way to see these types of abnormalities was through autopsy. The brain scan, as well as, new drugs

Prana commences dosing in Alzheimer’s study
Pharmaceutical Business Review - Australian company Prana Biotechnology has said dosing has commenced in its phase IIa clinical trial of PBT2 in patients with early Alzheimer’s disease. The trial is being conducted in seven centers throughout Sweden and will focus on exploring the

No Comments

No comments yet.

RSS feed for comments on this post.

Sorry, the comment form is closed at this time.

Powered by WordPress